AlphAIalphai — Financial news for AI agents
financialcontent.comAUG 114 min read$ATRO

Astronics’s (NASDAQ:ATRO) Q2 CY2026: Strong Sales, Stock Jumps 13.4%

Astronics Corp (NASDAQ:ATRO) reported Q2 CY2026 revenue of $260 million, up 27% year on year, topping Wall Street estimates by 6%. Non-GAAP EPS was $0.70, above consensus. Management guided next-quarter revenue to $270 million (midpoint). The stock rose 13.4% to $85.00 after results.

Original reporting
financialcontent.com
Published Aug 11, 2026, 9:45 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 11, 2026, 10:03 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
Astronics’s (NASDAQ:ATRO) Q2 CY2026: Strong Sales, Stock Jumps 13.4% — source image
Source · financialcontent.com
Decision brief

The 30-second read

$ATROBullishHigh
01

Why it matters

Q2 results beat revenue and EPS expectations, and next-quarter revenue guidance at the midpoint exceeded analyst expectations, supporting a positive repricing of near-term fundamentals.

02

Market read

The combination of a revenue beat, EPS beat, and above-consensus next-quarter guidance is a direct catalyst for trading ATRO around earnings and guidance follow-through.

03

What to watch

Operating margin is highlighted, but the piece does not break down segment drivers, backlog, cash flow, or order intake, which are key to sustaining the guidance.

Relevance 9/10Novelty 8/10Timing: after-hours/market reaction on 2026-08-11 following Q2 results

Background

Astronics is an aerospace and defense technology solutions provider, including power outlet integration for Boeing aircraft.

Company-level read

Ticker impact

$ATROBullishMedium confidence
Context

Astronics reported Q2 CY2026 revenue up 27% to $260M and non-GAAP EPS of $0.70, beating consensus, with next-quarter guidance at $270M midpoint.

Expected impact

Likely supports continued upside bias in the near term, though follow-through depends on whether guidance holds into subsequent quarters.

Evidence & confidence

The article provides concrete earnings and guidance numbers and cites a 13.4% same-session stock move, indicating the market repriced expectations immediately.

Market effects

Sector

Improves sentiment for aerospace and defense electronics suppliers by signaling demand strength and operating leverage.

Regional

No specific regional spillover mentioned beyond US-listed aerospace/defense equities.

Global

No explicit global macro or international contract details beyond general aerospace/defense demand.

Counterpoint

What could challenge this read

The article’s optimism may be partly valuation and momentum-driven; guidance could still be vulnerable if aerospace delivery schedules or defense budgets shift.

Key entities

  • company
    Astronics Corporation

    Reported Q2 CY2026 revenue growth, non-GAAP EPS beat, and next-quarter revenue guidance.

  • market_reference
    Wall Street estimates

    Used as the benchmark for the reported beat versus consensus.

Read at source← All news

Related articles

AUG 11
$ATROHigh

ASTRONICS CORP (ATRO): Results of Operations and Financial Condition

ASTRONICS CORP (ATRO) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex99120260704-pr.htm EX-99.1 Document Exhibit 99.1 Astronics Corporation • 130 Commerce Way • East Aurora, NY • 14052-2164 FOR IMMEDIATE RELEASE Astronics Corporation Reports Record Operating Income on 27% Sales Growth for Second Quarter 2026 • Second quarter sales incr

SEC EDGAR 8-K6 min
JUL 27
$ATROMed

Astronics Corporation Announces Favorable Appeal Ruling on Lufthansa Technik Intellectual Property Case in United Kingdom

Astronics (Nasdaq: ATRO) said a UK appellate court dismissed Lufthansa Technik AG’s appeal of a February 2025 damages ruling in their UK patent infringement case. The court granted one of Astronics’ appeals, requiring a partial refund of previously paid damages, with the amount to be determined, and possible additional attorney-fee amounts. Either party may seek UK Supreme Court review.

finanznachrichten.de3 min
JUN 27
$ATROMedAI 8/10

Analysts See 21% Upside To Astronics Corporation (ATRO)

Astronics (ATRO) shares were rated a “Strong Buy” with 21% average upside potential, according to analysts. TD Cowen’s Gautam Khanna raised its price target to $100 from $85 and kept a Buy rating after the U.S. Army awarded Astronics Test Systems an order for TS-4549/T Radio Test Sets. The $44.7 million order covers deliveries over 20 months.

finance.yahoo.com3 min
MAY 28
$ATROMedAI 9/10

Astronics Corporation (ATRO) Gains 49% YTD, 171% in 1Y

Astronics (ATRO) shares were up 49% year-to-date as of May 22 and 171% over the past 12 months, according to market data cited in the article. The report says Q1 2026 sales rose 12% to $230.6 million, with net income of $0.67 per diluted share. Adjusted EBITDA increased to $37.9 million; order bookings were $290.4 million, lifting backlog to $734.3 million. The company raised full-year revenue guidance to $970 million–$1 billion.

finance.yahoo.com3 min
AUG 11
$AXSMMed

Axsome Therapeutics Q2 Earnings Call Highlights

Axsome Therapeutics (AXSM) reported Q2 updates on AUVELITY, SYMBRAVO, and SUNOSI, including gross-to-net discounts and prescription growth. AUVELITY was launched for Alzheimer’s agitation, with total prescriptions about 266,000. SYMBRAVO prescriptions rose to about 23,500. FDA accepted AXS-12 NDA with a May 1, 2027 target date. Costs and expenses were also detailed.

yahoo.com6 min
AUG 11
$NIUMed

Niu Technologies Q2 Earnings Call Highlights

Niu Technologies (NASDAQ:NIU) reported Q2 results and discussed margin pressure. China scooter average selling price fell 9% to RMB 3,010. Gross profit declined to RMB 230 million and gross margin to 16%. GAAP net loss was RMB 102 million. For Q3, it forecast revenue of RMB 1.86 billion to RMB 2.03 billion.

yahoo.com6 min